Nuvalent股价飙升 此前GSK宣布收购该公司

环球市场播报
Jun 09

  英国生物制药公司葛兰素史克宣布以106亿美元收购美国药企Nuvalent,后者股价随即飙升近39%。

  这项全现金交易对Nuvalent的估值约为每股124美元。Nuvalent目前有两款治疗某种肺癌的药物正在接受美国食品药品监督管理局的审评。

  葛兰素史克首席执行官卢克·米尔斯在新闻稿中表示,此次收购将为公司带来即时的新的销售增长机遇。这家药企在美国上市的股票周二盘前交易中下跌1%。

海量资讯、精准解读,尽在新浪财经APP

责任编辑:张俊 SF065

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10